Notícias Amryt Pharma Plc - AMYT | Ações Bolsa de Valores de Londres | ADVFN Brasil

Índice Bovespa

US Dollar vs BRL

As Melhores Corretoras Online

Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

Cadastre-se

Amryt Pharma Plc (AMYT)

143,00

0,00

(0,00%)

Fechado 10 Março 1:30PM

Atrasado por 15 minutos

Discussões em tempo real e ideias de negociação: Negocie com confiança com nossa poderosa plataforma.

Amryt Pharma plc Amryt Announces The Appointment Of Sheila Frame As President Americas

Amryt Pharma plc Amryt Submits A New Drug Application To The Us Food And Drug Administration For Oleogel-S10* (Filsuvez(R))

Amryt Pharma plc Amryt Announces Results From An Investigator Sponsored Study Of Lomitapide In Fcs

Amryt Pharma plc Amryt Announces Validation Of Its Maa By The Ema For Oleogel-S10*(Filsuvez(R))

IN BRIEF: Amryt gets positive feedback on Myalept from US regulator

Amryt Pharma plc Amryt Receives Positive Feedback From The Fda On The Path Forward For Myalept(R) (metreleptin) Indication In...

IN BRIEF: Amryt's Myalepta secures reimbursement approval in France

Amryt Pharma plc Amryt Receives Reimbursement Approval From The French Ministry Of Social Affairs And Health For Myalepta(R) ...

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Exercise Of Options And Total Voting Rights

Amryt Pharma plc Exercise Of Warrants & Issue Of Ordinary Shares And Total Voting Rights

IN BRIEF: Amryt, Medison sign distribution deal for Myalepta in Canada

Amryt Pharma plc Director/Pdmr Shareholding

Amryt Pharma plc Amryt And Medison Pharma Sign Distribution Agreement For Myalepta(R) (metreleptin) In Canada

TRADING UPDATES: Origin Enterprises loss slims; Amryt issues guidance

2
3
4
Próxima

Fóruns

Nenhuma Discussão Encontrada

Criar Nova Discussão

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições